2018
DOI: 10.1089/ars.2016.6883
|View full text |Cite
|
Sign up to set email alerts
|

Ceruloplasmin, a Potential Therapeutic Agent for Alzheimer's Disease

Abstract: Our results show a protective role of CP in AD and suggest that regulating CP expression in the hippocampus may provide a new neuroprotective strategy for AD. Antioxid. Redox Signal. 28, 1323-1337.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
30
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 29 publications
(30 citation statements)
references
References 42 publications
0
30
0
Order By: Relevance
“…We investigated whether H 2 -O 2 mixture enhanced the antioxidant capacity to protect against CIH-induced oxidative stress injury. SOD and GSH are essentially endogenous antioxidants that scavenge superoxide anion radicals and hydrogen peroxide [30]. T-SOD and GSH activities were substantially elevated in the CIH+H 2 group compared to the CIH group (Figures 5(a) and 5(b)).…”
Section: Resultsmentioning
confidence: 99%
“…We investigated whether H 2 -O 2 mixture enhanced the antioxidant capacity to protect against CIH-induced oxidative stress injury. SOD and GSH are essentially endogenous antioxidants that scavenge superoxide anion radicals and hydrogen peroxide [30]. T-SOD and GSH activities were substantially elevated in the CIH+H 2 group compared to the CIH group (Figures 5(a) and 5(b)).…”
Section: Resultsmentioning
confidence: 99%
“…We then evaluated whether Ndfip1 played a role in protecting against iron-induced cell injury, and the results revealed that excessive iron aggravated neuronal injury, whereas Ndfip1 overexpression reversed iron-induced cell damage. Several studies have demonstrated that reduction of brain iron accumulation is a potential strategy for AD prevention (Zheng et al, 2009 ; Guo et al, 2013a , b ; Zhang et al, 2018 ; Zhao et al, 2018 ). However, further studies are needed to evaluate whether regulation of brain iron homeostasis through enhancing Ndfip1 protein level is benefit for blocking the neuropathological process of AD.…”
Section: Discussionmentioning
confidence: 99%
“…Animal usage was approved by California Medical Innovations Institute (CalMI2) Institutional Animal Care and Use Committee (IACUC). The genotyping was conducted in CalMI2 animal facilities at the age of 21 days by tail DNA extraction according to our previous protocol and the online information supplied by the vendor. Eleven mice per strain (3xTg‐AD, B6129SF2/J) at the ages of 6, 9 and 12 mo were used in this study.…”
Section: Methodsmentioning
confidence: 99%